JM
Jesse Mcgreivy
Hematology & Oncology
Credentials: ·
Research
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
New England Journal of Medicine · 2013 · 1,377 citations
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia
New England Journal of Medicine · 2014 · 1,369 citations
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Nature Medicine · 2015 · 979 citations
4 papers · 2 as a fellow
- DB
3 papers
- JB
3 papers
3 papers
- SO
3 papers
2 papers
- EL
2 papers
2 papers
